Lydia Denworth is a New York-based science writer and author of I Can Hear You Whisper: An Intimate Journey through the Science of Sound and Language.
Lydia Denworth
Contributing writer
The Transmitter
From this contributor
The last two-author neuroscience paper?
Author lists on papers have ballooned, and it’s getting hard to discern contribution.
The promise of telehealth in autism diagnoses
The COVID-19 pandemic forced a reckoning, in which autism clinicians had to redefine best practices and expand how children are evaluated. The remote assessments they developed may help solve a persistent problem: the long wait families endure to get a diagnosis in the United States.
The promise of telehealth in autism diagnoses
The most personalized medicine: Studying your own child’s rare condition
A handful of scientists are committed to advancing research on the autism-related genetic conditions their own children have.
The most personalized medicine: Studying your own child’s rare condition
Owen’s odyssey: A year and a half after an autism diagnosis
This is part 2 of Owen’s story. It tracks his early progress in treatment for autism. Part 1 described his difficult path to a diagnosis.
Owen’s odyssey: A year and a half after an autism diagnosis
A quest for Quincy: Gene therapies come of age for some forms of autism
A gene therapy for Angelman syndrome stands at the forefront of efforts to treat autism-linked conditions that stem from single genes.
A quest for Quincy: Gene therapies come of age for some forms of autism
Explore more from The Transmitter
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.
Building brain-computer interfaces at a neurotech company
At Blackrock Neurotech, Spencer Kellis develops implantable devices that help people with brain and spinal cord conditions communicate, move and more.
Building brain-computer interfaces at a neurotech company
At Blackrock Neurotech, Spencer Kellis develops implantable devices that help people with brain and spinal cord conditions communicate, move and more.
‘High risk, high reward’: How early-career neuroscientists view their future
The Transmitter and Neuromatch surveyed more than 300 early-career neuroscientists to better understand their unique challenges, career aspirations and support needs.
‘High risk, high reward’: How early-career neuroscientists view their future
The Transmitter and Neuromatch surveyed more than 300 early-career neuroscientists to better understand their unique challenges, career aspirations and support needs.